Source comparison
Hexarelin Dosing: Research Protocol Comparison
Standard Research Protocol 100–200 mcg twice daily 4 weeks on, 4 weeks off Morning (fasted) + pre-sleep (2h post-meal) 4–7× baseline Optimal for controlled studies requiring consistent pulsatility without desensitization Continuous Daily Dosing No off-cycle Va
This comparison does not assign a generated winner or score.
- Standard Research Protocol
- 100–200 mcg twice daily
- 4 weeks on, 4 weeks off
- Morning (fasted) + pre-sleep (2h post-meal)
- 4–7× baseline
- Optimal for controlled studies requiring consistent pulsatility without desensitization
- Continuous Daily Dosing
- No off-cycle
- Variable timing
- 4–7× baseline (weeks 1–3), 2–3× baseline (week 4+)
- High desensitization risk. Response declines sharply after week 3–4
- Microcycle Protocol
- 5 days on, 2 days off (within 4-week macrocycle)
- 4–6× baseline maintained longer
- May reduce receptor downregulation but adds dosing complexity
- Single Daily Dose
- 200–300 mcg once daily
- Pre-sleep only
- 3–5× baseline
- Suboptimal. Misses morning GH pulse opportunity, higher single-dose side effect risk